Skip to main content
Birkhäuser

Alternative Mechanisms of Multidrug Resistance in Cancer

  • Book
  • © 1995

Overview

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

Keywords

About this book

Nullius in verba. . . Truth will be tested not by words. Horace (Epistles) Few read introductions except for book reviewers, who want to take a shortcut and avoid reading the book itself. However, tradition requires that the preface make public why the book was written at all (this is not supposed to include powerful reasons such as augmenting the ego of the editor and authors). Frequently, the inflationary tendency to publish in verbose length is in conflict with market forces and interest. No doubt, multidrug resistance is a "fashionable" topic, but there are many fashions displayed on the cat-walk of scientific literature. One can rationalize that the forces driving our concern with multi drug resistance reflect the frustration of pharmaceutical companies and oncologists alike: as soon as a new anticancer drug enters clinical trials, cancer cells start eluding extinction with their elaborate and successful mechanisms. Many grants have been awarded and spent, only to confirm the futility of our efforts to defeat this cellular Darwinism. Our medical and scientific training makes it hard, if not impossible, to accept that the survival of a malignant cell, alone or as part of a tissue, is part of the continuance of life. Since exposure to noxious and lethal substances is unavoidable, cells have been forced to develop a multitude of mechanisms to prevent entry or accelerate exit of such materials from intracellular space.

Editors and Affiliations

  • Sunnybrook Health Science Center, University of Toronto, Toronto, Canada

    John A. Kellen

Bibliographic Information

  • Book Title: Alternative Mechanisms of Multidrug Resistance in Cancer

  • Editors: John A. Kellen

  • DOI: https://doi.org/10.1007/978-1-4615-9852-7

  • Publisher: Birkhäuser Boston, MA

  • eBook Packages: Springer Book Archive

  • Copyright Information: Birkhäuser Boston 1995

  • Softcover ISBN: 978-1-4615-9854-1Published: 12 February 2012

  • eBook ISBN: 978-1-4615-9852-7Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: 281

  • Topics: Oncology, Pharmacology/Toxicology, Cancer Research, Drug Resistance

Publish with us